General Information of Drug (ID: DMKP6BM)

Drug Name
2-Methylamino-succinic acid(NMDA) Drug Info
Synonyms
N-Methyl-D-aspartic acid; N-methyl-D-aspartic acid; NMDA; 6384-92-5; N-Methyl-D-aspartate; N-Methylaspartate; D-Aspartic acid, N-methyl-; N-Me-D-Asp-OH; (R)-2-(Methylamino)succinic acid; NMDA (N-Methyl-D-aspartic acid); Methyl aspartic acid; n-methyl-d-aspartic acid (nmda); UNII-1903B9Q6PI; N-Methyl aspartic acid; (2R)-2-(methylamino)butanedioic acid; 2-Methylamino-succinic acid; BRN 1724431; CHEMBL291278; CHEBI:31882; HOKKHZGPKSLGJE-GSVOUGTGSA-N; 1903B9Q6PI; N-Methyl-D-aspartic Acid, Hydrate; AK-44365; W-203368; N-Methyl-D-aspartic acid, 98%
Cross-matching ID
PubChem CID
22880
ChEBI ID
CHEMBL31882
CAS Number
CAS 6384-92-5
TTD Drug ID
D06GKL

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
Systemic lupus erythematosus 2.32 0.00e+0 45/135 (33.33%) HLA-DMB;HLA-DQA1;HLA-DQB1;...
Asthma 2.17 0.00e+0 25/31 (80.65%) FCER1A;FCER1G;HLA-DMB;...
Allograft rejection 2.12 0.00e+0 32/38 (84.21%) GZMB;HLA-DMB;HLA-DQA1;...
Autoimmune thyroid disease 2.10 0.00e+0 46/53 (86.79%) GZMB;HLA-DMB;HLA-DQA1;...
N-Glycan biosynthesis 2.05 0.00e+0 38/50 (76%) MAN2A1;MGAT4A;FUT8;...
Various types of N-glycan biosynthesis 2.00 0.00e+0 26/39 (66.67%) MAN2A1;MGAT4A;FUT8;...
Viral myocarditis 1.92 4.12e-3 53/60 (88.33%) EIF4G1;HLA-DMB;HLA-DQA1;...
Leishmaniasis 1.87 1.26e-2 67/77 (87.01%) PRKCB;STAT1;ITGAM;...
B cell receptor signaling pathway 1.75 3.21e-2 71/81 (87.65%) NFATC3;PRKCB;MAP2K2;...
Type I diabetes mellitus 1.75 3.18e-2 38/43 (88.37%) GZMB;HLA-DMB;HLA-DQA1;...
Th1 and Th2 cell differentiation 1.75 2.89e-2 80/92 (86.96%) NFATC3;STAT1;MAF;...
Graft-versus-host disease 1.72 3.37e-2 32/42 (76.19%) GZMB;HLA-DMB;HLA-DQA1;...
Primary immunodeficiency 1.68 5.00e-2 33/38 (86.84%) ADA;RFX5;BLNK;...
Intestinal immune network for IgA production 1.68 4.85e-2 38/48 (79.17%) HLA-DMB;HLA-DQA1;HLA-DQB1;...
Salivary secretion 1.68 4.52e-2 76/93 (81.72%) PRKCB;CST3;CAMP;...
Thiamine metabolism -1.77 4.34e-2 12/15 (80%) AK5;TPK1;AK2;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone
Ewing sarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SK-ES-1 CVCL_0627 Homo sapiens 1.11uM - 10uM 24H
Brain
Glioma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
GI-1 CVCL_1230 Homo sapiens 1.11uM - 10uM 24H
Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MDA-MB-468 CVCL_0419 Homo sapiens 1.11uM - 10uM 24H
Breast ductal carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
T-47D CVCL_0553 Homo sapiens 1.11uM - 10uM 24H
Colon
Colorectal adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
SNU-407 CVCL_5004 Homo sapiens 1.11uM - 10uM 24H
Endometrium
Endometrial adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
HEC-108 CVCL_2926 Homo sapiens 1.11uM - 10uM 24H
HEC-1-A CVCL_0293 Homo sapiens 1.11uM - 10uM 24H
HEC-251 CVCL_2928 Homo sapiens 1.11uM - 10uM 24H
HEC-265 CVCL_2929 Homo sapiens 1.11uM - 10uM 24H
Hematopoietic system
Normal
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CJM CVCL_U797 Homo sapiens 1.11uM - 10uM 24H
Liver
Hepatocellular carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
JHH-5 CVCL_1320 Homo sapiens 1.11uM - 10uM 24H
Lung
Lung adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H1573 CVCL_1483 Homo sapiens 1.11uM - 10uM 24H
Lung squamous cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BEN CVCL_1081 Homo sapiens 1.11uM - 10uM 24H
HCC95 CVCL_1276 Homo sapiens 1.11uM - 10uM 24H
Non-small cell lung carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
NCI-H2110 CVCL_1529 Homo sapiens 1.11uM - 10uM 24H
Muscle
Rhabdomyosarcoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
A-204 CVCL_0134 Homo sapiens 1.11uM - 10uM 24H
Ovary
Ovarian clear cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
OVTOKO CVCL_3114 Homo sapiens 1.11uM - 10uM 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
22Rv1 CVCL_1045 Homo sapiens 1.11uM - 10uM 24H
Skin
Melanoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
IGR-37 CVCL_1303 Homo sapiens 1.11uM - 10uM 24H
Mel-HO CVCL_1402 Homo sapiens 1.11uM - 10uM 24H
SH-4 CVCL_1692 Homo sapiens 1.11uM - 10uM 24H
Urinary bladder
Bladder carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
BC-3C CVCL_1079 Homo sapiens 1.11uM - 10uM 24H
Bladder transitional cell carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
CAL-29 CVCL_1109 Homo sapiens 1.11uM - 10uM 24H